...
首页> 外文期刊>Critical Reviews in Biomedical Engineering >Human Umbilical Cord-Derived Stem Cells: Isolation, Characterization, Differentiation, and Application in Treating Diabetes
【24h】

Human Umbilical Cord-Derived Stem Cells: Isolation, Characterization, Differentiation, and Application in Treating Diabetes

机译:人脐带衍生的干细胞:分离,表征,分化和治疗糖尿病的应用

获取原文
获取原文并翻译 | 示例
           

摘要

Stem cell therapy is one of the most promising and effective approaches for treating diabetes,due to stem cell nonimmunogenic and nonimmunosupressive properties. Mesenchymal stem cells (MSCs) derived from human umbilical cord have been widely used in cell-based therapies for clinical applications. Among their various properties, immunomodulatory and proregenerative capacities broaden their scope for treating diabetes. Owing to various problems that are involved in treating diabetes, our review focuses on modulating umbilical cord-derived MSCs (UCMSCs) without any genetic manipulation. Umbilical cord tissue contains a rich source of MSCs with intact stemness. UCMSCs have profound effects on the remodeling process, maintaining similar morphology to various organs and escalating vascularization. Because of their neonatal origin,MSCs have enormous immune properties that lead to greater therapeutic benefits, including enhanced insulin sensitivity in type 2 diabetic (T2D) animal models and treatment of complications such as diabetic ulcers and compromised wound healing. MSCs ameliorate hyperglycemia by reducing inflammation due to their anti-inflammatory nature. Furthermore, their differentiation potential enables use in T1D treatment, wherein MSCs alone or insulin-producing cells that are derived from these MSCs, when transplanted in streptozotocin,induce animals to experience reversal of hyperglycemia. In this review, we discuss methods of UCMSC isolation, characterization, differentiation potential, and various applications in diabetes treatment.
机译:干细胞疗法是治疗糖尿病的最有希望和有效的方法之一,由于干细胞非免疫性和非免疫抑制性能。衍生自人脐帘线的间充质干细胞(MSCs)已广泛用于基于细胞的临床应用的疗法。在各种性质中,免疫调节和预处理能力扩大了治疗糖尿病的范围。由于涉及治疗糖尿病的各种问题,我们的审查重点是调制脐带衍生的MSCs(UCMSCs)而无需任何遗传操纵。脐带组织含有具有完整茎的丰富的MSC来源。 UCMSCS对重塑过程具有深远的影响,维持对各种器官和血管化的类似形态。由于其新生儿来源,MSCs具有巨大的免疫特性,可导致更大的治疗益处,包括增强2型糖尿病(T2D)动物模型的胰岛素敏感性,以及糖尿病溃疡的并发症和受损的伤口愈合。 MSCS通过减少由于其抗炎性而减少炎症来改善高血糖症。此外,它们的分化潜力能够在T1D处理中使用,其中当在链脲佐菌素中移植时,源自这些MSC的MSCs或胰岛素产生的细胞,诱导动物以体验高血糖逆转。在本次综述中,我们讨论了UCMSC隔离,表征,分化潜力和糖尿病治疗中的各种应用方法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号